Braveheart Investment Group PLC (LON:BRH) noted that investee company Pharm2Farm (P2F) has ordered an automated face mask production line that should be commissioned by the end of 2020. The production line has the capacity to produce up to five million standard or anti-viral face masks per month, said the investment company. Braveheart pointed out that conventional surgical type masks are recommended to be used for a maximum of two hours but P2F’s version contains an additional defensive layer that uses nanotechnology engineered to kill viruses and bacteria.

Remote Monitored Systems PLC (LON:RMS), which agreed to acquire Braveheart’s 51.7%  stake in P2F in August, simply noted the announcement in a statement today.

Faron Pharmaceuticals Ltd (LON:FARN) has said a scientist leading a trial of its early-stage immuno-oncology drug will provide more context on the treatment’s “promising” anti-tumour activity at a leading industry conference. Dr Petri Bono, principal investigator heading the phase I/II MATINS study of bexmarilimab, will also provide commentary around the drug’s potential efficacy. His team has observed a long-lasting partial response in a person with metastatic colorectal cancer and target lesion responses from “heavily pre-treated” melanoma and ovarian cancer patients.

Emmerson PLC’s (LON:EML) new chief executive Graham Clarke has told investors he looks forward to regular progress updates as the potash mine group moves through a critical stage in its history. Clarke joined the company shortly after June’s feasibility study for Khemisset which confirmed the mine as a world-class, low capital cost, high margin potash mine. It envisaged outstanding project economics including earnings margins in excess of 61% over a 19-year minimum mine life. Subsequently, the company focus has shifted to making Khemisset “shovel ready”.

SIMEC Atlantis Energy Ltd (LON:SAE) shares are tipped to treble in value as the renewable energy pioneer continues to advance key projects. Investec has initiated its coverage with a ‘buy’ recommendation which comes with a 75p price target, compared to a prevailing market price of 26.25p. Analyst Martin Young described SIMEC Atlantis as “a triple play on sustainability” monetising end-of-life waste, tidal stream power, and small-scale hydro.

Arix Bioscience PLC (LON:ARIX) has noted new data has been published by portfolio company Autolus Therapeutics PLC (NADSDAQ:AUTL). The release highlights progress on AUTO3, a CAR T cell therapy being investigated in a Phase 1/2 clinical trial in relapsed/refractory diffuse large B cell lymphoma (DLBCL), a cancer that starts in white blood cells. “The data support a best in class profile with a high level of complete remissions and a well tolerated safety profile,” said Dr. Christian Itin, chairman and chief executive officer of Autolus.

Polarean Imaging PLC (LON:POLX) has completed the installation of its 9820 Xenon Polariser system at the University of Kansas (KU) Medical Center. KU is a major research and teaching hospital and the new technology will form the cornerstone of a new hyperpolarised 129Xe imaging research programme, added the company, which has now installed 23 systems. The latest unit will be used to “evaluate and assess” responses to therapy in lung disease patients, KU’s Dr Mario Castro said in a statement. Polarean has developed a drug-device combination which uses hyperpolarised 129-Xenon gas MRI.

Integumen PLC (LON:SKIN), which will soon be renamed DeepVerge PLC, reported a positive first half and said it remains comfortable guiding for £4mln of full year revenue. Achieving that target will see a significant ramp-up. The company generated some £1.004mln of revenue in the first six months of 2020, and it expected to bring in another £1mln in the third quarter and then the fourth. Integumen chief executive Gerard Brandon pointed out that the business continues to grow and evolve via collaboration and acquisition. Most recently, in August, the company agreed to a £21.25mln merger with Modern Water PLC (LON:MWG).

Iconic Labs PLC (LON:ICON) has said that revenues from its new contract to provide social content through JOE Media’s accounts will be roughly £100,000. The London-based company confirmed it has already started work under the management services agreement with JOE Media, with the contract scheduled to conclude in the second quarter of 2021, which is extended from its original guidance last month that it would end in the fourth quarter of this year, though the contract was expected to be nearer £150,000 then. JOE Media’s owner, Greencastle Capital. will extend the agreement to JOE’s Ireland operations following their expected acquisition, which has been delayed and is now anticipated early next month. Separately, Iconic Labs said that it has received notice from European High Growth Opportunities Securitization Fund of the exercise of its conversion rights under the Convertible Bonds issued in respect of the sixth and seventh tranches drawn down under the Financing and Settlement Agreement for the aggregate principal amount of £350,000 resulting in the issue to the Investor of 5,000,000,000 new ordinary shares

Eurasia Mining PLC (LON:EUA), the Russia-focused platinum miner, has reshuffled its executive team with non-executive director James Nieuwenhuys to become its new chief executive. Christian Schaffalitzky remains as executive chairman while Dmitry Suschov steps down from the board to become chief M&A officer. Nieuwenhuys has previously been CEO South Africa’s Lesego Platinum and was COO at Polyus Gold, Russian largest gold producer and has many contacts among PGM producers in Russia, China and South Africa, said Eurasia. In a separate statement,  Eurasia Mining announced that resolutions 1-7 were passed at its annual general meeting (AGM) on Friday but that due to COVID-related delays in processing the votes held in nominee accounts, special resolutions 8 and 9 have not been passed. The company said it does not intend to pursue these resolutions having now fulfilled its funding requirements. It also said a new company presentation has now been uploaded to its website and may be reached by the following link:  

Trident Royalties PLC (LON:TRR) has announced the appointment of Helen Pein as an independent non-executive director, joining with immediate effect. The company noted that Pein is a highly experienced economic geologist with a 30-year career that has spanned multiple commodities and geographies. “I am delighted that Helen will be joining the board of Trident,” said James Kelly, Trident chairman in a statement.

Vast Resources PLC (LON:VAST) has told investors that work to install a new steel bridge at the Baita Plai mine site in Romania is to start today. The group announced earlier this month that operations at Baita Plai had paused temporarily due to safety concern over a railway bridge between the mine and the flotation plant. The brief hiatus was expected to delay first concentrate sales by three to four weeks. Vast recently raised £1.68mln of new capital via a share placing, with some of the new funds earmarked to support the company as it resolved the transport infrastructure problem.

APQ Global Limited (LON:APQ) has announced that as at the close of business on August 31, 2020, its unaudited book value per ordinary share was 29.71 US cents, equivalent to 22.19p.

Alien Metals Limited (LON:UFO), a minerals exploration and development company, said that, following the receipt of exercise notices, it has issued 56,250,000 ordinary shares in the company at an issue price of 0.15p per share and 16,041,667 new ordinary shares of no par value in the company at an issue price of 0.12p per share.

Thor Mining PLC (LON:THR) (ASX:THR) said it has received a binding notice for the exercise of 9,450,000 warrants over ordinary shares of 0.01 pence each in the capital of the company, each with an exercise price of 0.2p per warrant. The gross proceeds of the exercise of these warrants amounts in aggregate to £18,900.

Chaarat Gold Holdings Limited (LON:CGH), the AIM-quoted gold mining Company with an operating mine in Armenia and assets at various stages of development in the Kyrgyz Republic, said it has been informed that Labro Investments Limited, the majority of shares in which the company’s chairman, Martin Andersson, is indirectly beneficially interested, on September 16, 2020, purchased 144,134 ordinary shares in the company at an aggregate price of approximately 37.31p each, and on September 17, 2020, acquired a further 180,000 ordinary shares at an aggregate price of 37.72p each. Following these purchases, Labro now holds 203,475,349 ordinary shares, representing 38.79% of the company’s issued share capital.  The combined holding of Labro and Martin Andersson is now 209,305,345 ordinary shares representing 39.90% of the company’s issued share capital.

Sativa Group PLC (LON:SATI) is to change its name to Sativa Wellness Group Inc when it re-lists in London and Canada following the merger with StillCanna Inc. The re-listing, on the Aquis Exchange in London and Canadian Stock Exchange, is now expected around the end of September, the company said in a statement.

FastForward Innovations Ltd. (LON:FFWD), the AIM-quoted company focusing on making investments in fast-growing and industry-leading businesses, announce that at its annual general meeting held on Thursday, all resolutions which were proposed to shareholders were duly passed.

Newmark Security PLC (LON:NWT), a leading provider of electronic and physical security systems, has said its 2020 annual general meeting (AGM), will be held at 11.00am on October 13, 2020. The directors have made the difficult decision to restrict access to the AGM in light of the coronavirus (COVID-19) pandemic and shareholders are strongly encouraged to vote via completion of a Form of Proxy, and to appoint the chairman of the meeting as proxy to ensure votes are counted. Any shareholders who have any questions related to the business of the AGM should submit these to and the directors will ensure that a response is provided either individually or via the company’s website.

InnovaDerma (LON:IDP), a UK developer of beauty, personal care and life sciences products, has said it will announce its full-year results for the year ended June 30, 2020, on Wednesday, September 30, 2020. The management of InnovaDerma will deliver an online results presentation open to all existing and potential investors via the Investor Meet Company platform on the same day at 9.00am UK time. Investors can sign up for free via:

Hardman & Co Research has issued a note on Shield Therapeutics PLC(LON:STX) citing optimism after the group’s management indicated that several discussions are ongoing to secure an optimal commercial deal for the US, which reassured the market, while, on current assumptions, they said the company has a cash runway into the first quarter of 2021. For the full report, investors can click on the following link: